Lycegalin-NT Tablet contains a combination of Pregabalin 75 mg and Nortriptyline 10 mg, formulated for the management of neuropathic pain and certain mood disorders. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channels in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission by inhibiting the reuptake of norepinephrine and serotonin, contributing to both analgesic and antidepressant effects. This combination is particularly effective in patients experiencing chronic neuropathic pain associated with diabetic neuropathy, postherpetic neuralgia, or fibromyalgia, where pain relief and mood stabilization are essential. Lycegalin-NT is administered orally, with dosing individualized based on patient response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, glaucoma, or renal impairment. The combination therapy aims to provide synergistic benefits by targeting multiple pain pathways and improving overall patient quality of life. Lycegalin-NT should be used under medical supervision, with gradual dose adjustments to minimize side effects and optimize therapeutic outcomes.